The Effect of Age and Type of Media on Growth Kinetics of Human Amniotic Fluid Stem cells.

Aim: This study compared growth kinetics of human amniotic fluid stem cells (hAFSCs) in different maternal age groups and two different media of AmnioMAX and Dulbecco's modified Eagle's medium (DMEM). Materials and Methods: Three milliliters of amniotic fluid (AF) was provided from 16 pregnant women who were referred for amniocentesis from 16 to 18 weeks of gestation. Mothers were divided to 20-29 (n = 5), 30-39 (n = 5) and 40-49 (n = 6) years old age groups. AF was immediately centrifuged and the cell pellet was cultured. Cells were characterized morphologically, by flow cytometry and for osteogenic and adipogenic inductions. Population doubling time (PDT) and growth kinetics were determined. AFSCs cultured in AmnioMAX were compared in various age groups. A comparison of growth kinetics of AFSCs cultured in AmnioMAX and DMEM from 40 to 49 years old pregnant women was undertaken. Results: AFSCs were adherent to culture flasks and were spindle shape, and positive for osteogenic and adipogenic inductions and for expression of CD73, CD90 and CD105 markers, but negative for CD34 and CD45. PDT among 20-29, 30-39, and 40-49 years old women was 30.9, 38.3, and 43.9 hours, respectively showing a higher cell proliferation in younger ages. When comparing AmnioMAX and DMEM, PDT was 53 and 96.9 hours, respectively denoting to a higher cell proliferation in AmnioMAX. Conclusions: Higher proliferation and plasticity of hAFSCs were noted in AmnioMAX and in younger mothers' samples. These findings can be added to the literature and open a new avenue in regenerative medicine, when hAFSCs are targeted for cell therapy purposes.

[1]  S. Hashemi,et al.  The effect of allogenic human Wharton's jelly stem cells seeded onto acellular dermal matrix in healing of rat burn wounds , 2020, Journal of cosmetic dermatology.

[2]  A. Atala,et al.  Effect of Human Amniotic Fluid Stem Cells on Kidney Function in a Model of Chronic Kidney Disease. , 2019, Tissue engineering. Part A.

[3]  S. Ahadian,et al.  MRI-Tracking of Dental Pulp Stem Cells In Vitro and In Vivo Using Dextran-Coated Superparamagnetic Iron Oxide Nanoparticles , 2019, Journal of clinical medicine.

[4]  S. Naz,et al.  Isolation and culture of dental pulp stem cells from permanent and deciduous teeth , 2019, Pakistan journal of medical sciences.

[5]  A. Mohammadi,et al.  The healing effect of Wharton's jelly stem cells seeded on biological scaffold in chronic skin ulcers: A randomized clinical trial , 2019, Journal of cosmetic dermatology.

[6]  Alan M. Hirahara,et al.  Are Amniotic Fluid Products Stem Cell Therapies? A Study of Amniotic Fluid Preparations for Mesenchymal Stem Cells With Bone Marrow Comparison , 2019, The American journal of sports medicine.

[7]  A. Khodakaram-Tafti,et al.  Comparison of the regenerative effect of adipose‐derived stem cells, fibrin glue scaffold, and autologous bone graft in experimental mandibular defect in rabbit , 2018, Dental traumatology : official publication of International Association for Dental Traumatology.

[8]  D. Ochiai,et al.  The neurorestorative effect of human amniotic fluid stem cells on the chronic phase of neonatal hypoxic–ischemic encephalopathy in mice , 2018, Pediatric Research.

[9]  Runchana Markmee,et al.  Osteoblastic differentiation potential of human amniotic fluid-derived mesenchymal stem cells in different culture conditions. , 2018, Acta histochemica.

[10]  U. Galderisi,et al.  Mesenchymal stromal cells from amniotic fluid are less prone to senescence compared to those obtained from bone marrow: An in vitro study , 2018, Journal of cellular physiology.

[11]  B. Young,et al.  Human term amniotic fluid: a novel source of stem cells for regenerative medicine , 2018, American journal of obstetrics and gynecology.

[12]  P. Gressens,et al.  Neuroprotection of the hypoxic-ischemic mouse brain by human CD117+CD90+CD105+ amniotic fluid stem cells , 2018, Scientific Reports.

[13]  Kunfu Wang,et al.  Biological characterization and pluripotent identification of ovine amniotic fluid stem cells , 2018, Cytotechnology.

[14]  Ankita Srivastava,et al.  Amniotic Fluid Stem Cells: A New Era in Regenerative Medicine , 2018, The Journal of Obstetrics and Gynecology of India.

[15]  A. Chao,et al.  Human amniotic fluid stem cells have better potential in early second trimester of pregnancy and can be reprogramed to iPS. , 2017, Taiwanese journal of obstetrics & gynecology.

[16]  T. Fehm,et al.  Isolation and Molecular Characterization of Amniotic Fluid-Derived Mesenchymal Stem Cells Obtained from Caesarean Sections , 2017, Stem cells international.

[17]  M. Griffin,et al.  Systematic review of patient factors affecting adipose stem cell viability and function: implications for regenerative therapy , 2017, Stem Cell Research & Therapy.

[18]  Amin Tamadon,et al.  The growth kinetic, differentiation properties, karyotyping, and characterization of adipose tissue-derived stem cells in hamster , 2016, Comparative Clinical Pathology.

[19]  C. Catacchio,et al.  Characterization and in vitro differentiation potency of early‐passage canine amnion‐ and umbilical cord‐derived mesenchymal stem cells as related to gestational age , 2014, Molecular reproduction and development.

[20]  D. Harris,et al.  Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation , 2014, Journal of Translational Medicine.

[21]  N. Sebire,et al.  Placenta as a reservoir of stem cells: an underutilized resource? , 2013, British medical bulletin.

[22]  A. Angelini,et al.  Stem-cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  Tetsuro Kobayashi,et al.  Molecular biological and immunohistological characterization of canine dermal papilla cells and the evaluation of culture conditions. , 2011, Veterinary dermatology.

[24]  C. Tseng,et al.  Isolation of Mesenchymal Stem Cells with Neurogenic Potential from the Mesoderm of the Amniotic Membrane , 2010, Cells Tissues Organs.

[25]  D. Schmidt,et al.  Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? , 2009, Regenerative medicine.

[26]  V. Fossati,et al.  Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro , 2007, BMC Developmental Biology.

[27]  P. Rebulla,et al.  Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential , 2006, Cell Research.

[28]  G. Mitteregger,et al.  Primary cell culture and morphological characterization of canine dermal papilla cells and dermal fibroblasts. , 2002, Veterinary dermatology.